490 related articles for article (PubMed ID: 24768200)
1. [Non-alcoholic fatty liver in children and adolescents with excess weight and obesity].
Guijarro de Armas MG; Monereo Megías S; Navea Aguilera C; Merino Viveros M; Vega Piñero MB
Med Clin (Barc); 2015 Jan; 144(2):55-8. PubMed ID: 24768200
[TBL] [Abstract][Full Text] [Related]
2. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
[TBL] [Abstract][Full Text] [Related]
3. Anthropometric measures of visceral and subcutaneous fat are important in the determination of metabolic dysregulation in boys and girls at risk for nonalcoholic fatty liver disease.
Mager DR; Yap J; Rodriguez-Dimitrescu C; Mazurak V; Ball G; Gilmour S
Nutr Clin Pract; 2013 Feb; 28(1):101-11. PubMed ID: 23042833
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity.
Jimenez-Rivera C; Hadjiyannakis S; Davila J; Hurteau J; Aglipay M; Barrowman N; Adamo KB
BMC Pediatr; 2017 Apr; 17(1):113. PubMed ID: 28446162
[TBL] [Abstract][Full Text] [Related]
5. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
Yi M; Chen RP; Yang R; Chen H
Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
[TBL] [Abstract][Full Text] [Related]
6. Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity.
OʼSullivan TA; Oddy WH; Bremner AP; Sherriff JL; Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Adams LA
J Pediatr Gastroenterol Nutr; 2014 May; 58(5):624-31. PubMed ID: 24345826
[TBL] [Abstract][Full Text] [Related]
7. Estimation of gamma-glutamyl transferase as a suitable simple biomarker of the cardiovascular risk in children with non-alcoholic fatty liver disease.
Bobrus-Chociej A; Flisiak-Jackiewicz M; Daniluk U; Wojtkowska M; Kłusek-Oksiuta M; Tarasów E; Lebensztejn D
Acta Biochim Pol; 2018 Oct; 65(4):539-544. PubMed ID: 30380561
[TBL] [Abstract][Full Text] [Related]
8. Screening for non-alcoholic fatty liver disease among obese and overweight children: Prevalence and predictors.
Thiagarajan S; Shrinuvasan S; Arun Babu T
Indian J Gastroenterol; 2022 Feb; 41(1):63-68. PubMed ID: 35064452
[TBL] [Abstract][Full Text] [Related]
9. Associations of physical activity and fitness with hepatic steatosis, liver enzymes, and insulin resistance in children with overweight/obesity.
Medrano M; Arenaza L; Migueles JH; Rodríguez-Vigil B; Ruiz JR; Labayen I
Pediatr Diabetes; 2020 Jun; 21(4):565-574. PubMed ID: 32237015
[TBL] [Abstract][Full Text] [Related]
10. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
[TBL] [Abstract][Full Text] [Related]
11. Ultrasonographic and biochemical evaluation of visceral obesity in obese women with non-alcoholic fatty liver disease.
Fenkci S; Rota S; Sabir N; Akdag B
Eur J Med Res; 2007 Feb; 12(2):68-73. PubMed ID: 17369120
[TBL] [Abstract][Full Text] [Related]
12. Liver enzymes but not free fatty acid levels predict markers of insulin sensitivity in overweight and obese, nondiabetic adults.
Gray B; Muhlhausler BS; Davies PS; Vitetta L
Nutr Res; 2013 Oct; 33(10):781-8. PubMed ID: 24074735
[TBL] [Abstract][Full Text] [Related]
13. Biochemical parameters response to weight loss in patients with non-alcoholic steatohepatitis.
Abd El-Kader SM; Al-Shreef FM; Al-Jiffri OH
Afr Health Sci; 2016 Mar; 16(1):242-9. PubMed ID: 27358638
[TBL] [Abstract][Full Text] [Related]
14. Elevation of glutamic pyruvic transaminase and gamma-glutamyl transpeptidase in obesity.
Nakamura S; Takezawa Y; Nakajima Y; Maeda T
Tohoku J Exp Med; 1980 Dec; 132(4):473-8. PubMed ID: 6114578
[TBL] [Abstract][Full Text] [Related]
15. Serum glutamic-oxaloacetic transaminase (GOT) and glutamic-pyruvic transaminase (GPT) levels in children and adolescents with intellectual disabilities.
Lin JD; Lin PY; Chen LM; Fang WH; Lin LP; Loh CH
Res Dev Disabil; 2010; 31(1):172-7. PubMed ID: 19828286
[TBL] [Abstract][Full Text] [Related]
16. Prevalence, risk factors, and predictors of nonalcoholic fatty liver disease among schoolchildren: a hospital-based study in Alexandria, Egypt.
Alkassabany YM; Farghaly AG; El-Ghitany EM
Arab J Gastroenterol; 2014 Jun; 15(2):76-81. PubMed ID: 25097051
[TBL] [Abstract][Full Text] [Related]
17. Association of adiponectin with hepatic steatosis: a study of 1,349 subjects in a random population sample.
Flechtner-Mors M; George SN; Oeztuerk S; Haenle MM; Koenig W; Imhof A; Boehm BO; Graeter T; Mason RA; Kratzer W; Akinli AS;
BMC Res Notes; 2014 Apr; 7():207. PubMed ID: 24693952
[TBL] [Abstract][Full Text] [Related]
18. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
[TBL] [Abstract][Full Text] [Related]
19. [Tests of liver function in obese school children].
Angulo N; de Szarvas SB; Guevara H; González D; Hernández A
Invest Clin; 2015 Mar; 56(1):13-24. PubMed ID: 25920182
[TBL] [Abstract][Full Text] [Related]
20. [Risk factors associated with non-alcoholic fatty liver disease: a case-control study].
Caballería L; Arteaga I; Pera G; Rodríguez L; Alumà A; Auladell MA; Torán P
Med Clin (Barc); 2013 Sep; 141(6):233-9. PubMed ID: 23601740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
